With the significant tightening in the market for VC financing, there have been meaningful changes in deal terms and bargaining power between startup companies and the VC funds that finance them. For that reason, it is more important than ever for founders to understand the latest developments in critical deal terms, along with the process and negotiating strategy in a VC financing round.
On October 26th, NY Tech Alliance will present a webinar featuring a panel of accomplished VC professionals, including an investor along with a lawyer and an accountant who advise on VC transactions, and a founder who has recently closed a VC round.
Together, the panel will address critical issues in VC transactions, including the following:
- Phases of the typical VC financing transaction, from term sheet through closing
- Understanding the purpose of a VC term sheet and the negotiation process
- Fundamental terms that appear in most VC preferred stock deals and current trends in the most important terms
- Strategies for negotiating the best possible deal in a down market
Whether you are currently pitching to VCs or are looking to do so in the future, this session will be an invaluable opportunity to hear from this seasoned panel about the essential considerations on this complex topic.
Bring your questions for the panelists, or send them in advance – time has been set aside.
11:30 - 12:00 - Virtual Networking
12:00 - 1:00 - Panel Discussion and Q&A
1:00 - 1:30 - Virtual Networking
As Managing Partner of the 12-lawyer Paul Ellis Law Group, Paul counsels on issues including formation, early-stage financing (friends and family, angel and VC), joint venture and strategic partnering relationships, employment, equity plans, mergers and acquisitions, and, together with his colleagues, protection and licensing of intellectual property. His experience spans multiple industries including software, digital media, e-commerce, healthcare, fintech and blockchain and cryptocurrency. He has represented companies ranging from startups to multinationals, as well as funds, family offices and individual investors. Clients choose Paul to negotiate complex business matters and provide sophisticated, strategic legal advice for establishing, financing, operating and exiting highly successful, and often rapidly-growing, companies.
Chris has over 25 years of experience in advancing cutting-edge biomedical information technology in the Healthcare & Life Sciences industry. Chris is a Managing Director in Xcellerant Ventures, the newest venture fund in Arizona focused on startups in healthcare. Chris most recently operated Yoo & Co Accelerators, the premier business accelerator in Arizona for healthcare & life sciences startups. Chris is an active angel investor and, as a serial entrepreneur, has created value in new companies that accelerate the adoption of smarter, technology-based systems such as cognitive computing, big data analytics, and systems engineering. Some of his prior ventures include Systems Oncology, an oncology biotechnology company, Systems Imagination, a pioneer in advanced cognitive computing for drug discovery, and MedTrust Online, the world’s first and largest online community of cancer doctors. He has also developed some of the earliest solutions and strategies in personalized medicine for companies such as Cisco, Applied Biosystems, Oracle, and IBM. Chris participates on the boards of several companies where he enjoys working arm-in-arm with the next generation of entrepreneurs and innovators. Chris is faculty at Arizona State University and Grand Canyon University teaching courses in molecular diagnostics and in entrepreneurship. He completed a postdoctoral fellowship at UC Berkeley, his PhD in Cell and Molecular Biology from Yale University School of Medicine, and a B.S. in History and Biology from the University of Pennsylvania.
Alan assists clients with capital budgeting, capital structuring and capital sourcing. Alan has 20 years of financial and consulting experience, having served as Director of the Interfunctional Management Consulting Program at Rutgers Graduate School of Management, a program he helped build into one of the largest business school-based management consulting practices in the country. He started his career in accounting, spending six years on the audit staff of a Big 4 accounting firm and a Fortune 500 Company. Alan left the accounting field to expand his horizons in the area of Corporate Finance. Alan spent several years as Director of Financial Analysis for AmBase Corporation (NYSE), where he led approximately $2 billion of corporate acquisition activity. He is also a past Vice President of Capricorn Management, a $100 million private equity fund specializing in restructuring and turnaround opportunities.
In addition, Alan is a leader in the firm’s Technology Group, providing a variety of industry-specific services to technology and life sciences firms, including business and strategic planning, marketing and competitive analyses, financing assistance, and operational and financial benchmarking. He has worked with many early stage and emerging growth companies on developing the appropriate capital structure for their position in the business life cycle. He maintains an active contact base with angel investors, venture capital funds and private equity funds. Alan also understands the level of returns private investors are trying to realize and devises strategies that allow both entrepreneurs and their investors to achieve desired return thresholds.
To register for this event on Zoom click here.
- October 26, 2023 at 11:30am – 1:30pm